The association of post-stroke anhedonia with salivary cortisol levels and stroke lesion in hippocampal/parahippocampal region
Carregando...
Citações na Scopus
17
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
DOVE MEDICAL PRESS LTD
Autores
IOSIFESCU, Dan V.
MATTOS, Patricia
LUCIA, Mara Cristina S. De
Citação
Neuropsychiatric Disease and Treatment, v.11, p.233-242, 2015
Resumo
Background: Anhedonia constitutes a coherent construct, with neural correlates and negative clinical impact, independent of depression. However, little is known about the neural correlates of anhedonia in stroke patients. In this study, we investigated the association of post-stroke anhedonia with salivary cortisol levels and stroke location and volume. Patients and methods: A psychiatrist administered the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition to identify anhedonia in 36 inpatients, without previous depression, consecutively admitted in a neurology clinic in the first month after a first-ever ischemic stroke. Salivary cortisol levels were assessed in the morning, evening, and after a dexamethasone suppression test. We used magnetic resonance imaging and a semi-automated brain morphometry method to assess stroke location, and the MRIcro program according to the Brodmann Map to calculate the lesion volume. Results: Patients with anhedonia had significantly larger diurnal variation (P-value =0.017) and higher morning levels of salivary cortisol (1,671.9 +/- 604.0 ng/dL versus 1,103.9 +/- 821.9 ng/dL; P-value =0.022), and greater stroke lesions in the parahippocampal gyrus (Brodmann area 36) compared to those without anhedonia (10.14 voxels; standard deviation +/- 17.72 versus 0.86 voxels; standard deviation +/- 4.64; P-value =0.027). The volume of lesion in the parahippocampal gyrus (Brodmann area 36) was associated with diurnal variation of salivary cortisol levels (rho=0.845; P-value =0.034) only in anhedonic patients. Conclusion: Our findings suggest that anhedonia in stroke patients is associated with the volume of stroke lesion in the parahippocampal gyrus and with dysfunction of the hypothalamic-pituitary-adrenal axis.
Palavras-chave
anhedonia, stroke, glucocorticoids, depression, hippocampus, parahippocampal
Referências
- Abercrombie HC, 2011, J PSYCHIATR RES, V45, P15, DOI 10.1016/j.jpsychires.2010.10.005
- Abramovitch A, 2014, PSYCHIAT RES, V216, P223, DOI 10.1016/j.psychres.2014.02.002
- Aihara M, 2007, PSYCHIAT RES-NEUROIM, V155, P245, DOI 10.1016/j.pscychresns.2006.11.002
- Almeida JRC, 2009, PSYCHIAT RES-NEUROIM, V174, P195, DOI 10.1016/j.pscychresns.2009.04.015
- American Psychiatric Association, 2013, DIAGN STAT MAN MENT
- Appelhof BC, 2006, BIOL PSYCHIAT, V59, P696, DOI 10.1016/j.biopsych.2005.09.008
- ASTROM M, 1993, STROKE, V24, P52
- Barugh AJ, 2014, J NEUROL, V261, P533, DOI 10.1007/s00415-013-7231-5
- Bhogal SK, 2004, STROKE, V35, P794, DOI 10.1161/01.STR.0000117237.98749.26
- Brodaty H, 2005, PSYCHOL MED, V35, P1707, DOI 10.1017/S0033291705006173
- BROTT T, 1989, STROKE, V20, P864
- Brouwer JP, 2006, PSYCHONEUROENDOCRINO, V31, P1154, DOI 10.1016/j.psyneuen.2006.08.001
- Carson AJ, 2000, LANCET, V356, P122, DOI 10.1016/S0140-6736(00)02448-X
- Castro M, 1999, J CLIN ENDOCR METAB, V84, P878, DOI 10.1210/jc.84.3.878
- Chase HW, 2010, PSYCHOL MED, V40, P433, DOI 10.1017/S0033291709990468
- Cincura C, 2009, CEREBROVASC DIS, V27, P119, DOI 10.1159/000177918
- Clarke David M, 2005, World Psychiatry, V4, P96
- Covinsky KE, 2014, AM J GERIAT PSYCHIAT, V22, P606, DOI 10.1016/j.jagp.2012.12.001
- Crespo-Facorro B, 2001, JAMA-J AM MED ASSOC, V286, P427, DOI 10.1001/jama.286.4.427
- Davidson KW, 2010, ARCH GEN PSYCHIAT, V67, P480, DOI 10.1001/archgenpsychiatry.2010.36
- Palacios RDY, 2011, BIOL PSYCHIAT, V70, P449, DOI 10.1016/j.biopsych.2011.05.014
- de Quervain DJF, 2003, EUR J NEUROSCI, V17, P1296, DOI 10.1046/j.1460-9568.2003.02542.x
- Dougherty LR, 2009, J CHILD PSYCHOL PSYC, V50, P1495, DOI 10.1111/j.1469-7610.2009.02116.x
- Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x
- EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813
- Farner L, 2009, INT J GERIATR PSYCH, V24, P1209, DOI 10.1002/gps.2247
- FASSBENDER K, 1994, STROKE, V25, P1105
- FEIBEL JH, 1977, JAMA-J AM MED ASSOC, V238, P1374, DOI 10.1001/jama.238.13.1374
- First MB, 1995, STRUCTURED CLIN INTE
- Fraguas Renerio Jr, 2002, Rev Assoc Med Bras, V48, P225, DOI 10.1590/S0104-42302002000300035
- Furlanetto LM, 2000, PSYCHOSOMATICS, V41, P426, DOI 10.1176/appi.psy.41.5.426
- Gabbay V, 2012, ARCH GEN PSYCHIAT, V69, P139, DOI 10.1001/archgenpsychiatry.2011.131
- Goldstein KE, 2009, SCHIZOPHR RES, V112, P14, DOI 10.1016/j.schres.2009.04.027
- Grool AM, 2012, PSYCHOL MED, V42, P359, DOI 10.1017/S0033291711001383
- Hasler G, 2008, ARCH GEN PSYCHIAT, V65, P521, DOI 10.1001/archpsyc.65.5.521
- Herbert J, 2013, PSYCHOL MED, V43, P449, DOI 10.1017/S0033291712000955
- Hinkelmann K, 2009, BIOL PSYCHIAT, V66, P879, DOI 10.1016/j.biopsych.2009.06.023
- Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7
- Hyett MP, 2008, J AFFECT DISORDERS, V109, P193, DOI 10.1016/j.jad.2007.11.005
- Insel TR, 2009, ARCH GEN PSYCHIAT, V66, P128, DOI 10.1001/archgenpsychiatry.2008.540
- Johansson A, 1997, J NEUROL SCI, V147, P43
- Juruena MF, 2013, J PSYCHOPHARMACOL, V27, P1169, DOI 10.1177/0269881113499205
- Keating C, 2012, NEUROPSYCHOLOGIA, V50, P567, DOI 10.1016/j.neuropsychologia.2012.01.036
- Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biophysh.2005.05.019
- Krishnan KRR, 1997, AM J PSYCHIAT, V154, P497
- Lavretsky H, 2008, INT J GERIATR PSYCH, V23, P1040, DOI 10.1002/gps.2030
- Leventhal AM, 2008, AM J ADDICTION, V17, P218, DOI 10.1080/10550490802019774
- MAHONEY F I, 1965, Md State Med J, V14, P61
- Martiny K, 2009, ACTA PSYCHIAT SCAND, V120, P196, DOI 10.1111/j.1600-0447.2009.01359.x
- Mead G, 2007, STROKE, V38, P2090, DOI 10.1161/STROKEAHA.106.478941
- Miller G, 2010, SCIENCE, V327, P1437, DOI 10.1126/science.327.5972.1437
- Monkul ES, 2012, HUM BRAIN MAPP, V33, P272, DOI 10.1002/hbm.21212
- Montag C, 2009, PSYCHOL MED, V39, P1831, DOI 10.1017/S0033291709005509
- Murakami T., 2013, PSYCHIATRY, V21, P840
- MURROS K, 1993, J NEUROL SCI, V116, P12, DOI 10.1016/0022-510X(93)90083-B
- Narushima K, 2003, J NEUROPSYCH CLIN N, V15, P422, DOI 10.1176/appi.neuropsych.15.4.422
- OLSSON T, 1992, STROKE, V23, P1573
- OLSSON T, 1989, STROKE, V20, P1685
- Papoiu ADP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082389
- Pariante CM, 2009, ANN NY ACAD SCI, V1179, P144, DOI 10.1111/j.1749-6632.2009.04978.x
- Pelle AJ, 2011, QUAL LIFE RES, V20, P643, DOI 10.1007/s11136-010-9792-4
- Pfeiffer PN, 2014, J AFFECT DISORDERS, V152, P277, DOI 10.1016/j.jad.2013.09.025
- PIAMARTA F, 2004, ARCH GERONTOLOGY G S, V9, P315
- Pizzagalli DA, 2014, ANNU REV CLIN PSYCHO, V10, P393, DOI 10.1146/annurev-clinpsy-050212-185606
- Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201
- Pringle A, 2013, J PSYCHOPHARMACOL, V27, P719, DOI 10.1177/0269881112474523
- Putnam KM, 2008, PSYCHOPHYSIOLOGY, V45, P886, DOI 10.1111/j.1469-8986.2008.00697.x
- Quaranta D, 2012, BEHAV NEUROL, V25, P303, DOI 10.3233/BEN-2012-110236
- Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925
- Sheline YI, 2000, BIOL PSYCHIAT, V48, P791, DOI 10.1016/S0006-3223(00)00994-X
- Shelton RC, 2001, PSYCHIATR SERV, V52, P1469, DOI 10.1176/appi.ps.52.11.1469
- Sibitz I, 2010, J AFFECT DISORDERS, V126, P245, DOI 10.1016/j.jad.2010.03.023
- Sibon I, 2012, CEREBROVASC DIS, V33, P280, DOI 10.1159/000334663
- Silva CEDE, 2013, CEREBROVASC DIS, V35, P385, DOI 10.1159/000348852
- Soriano-Mas C, 2011, BIOL PSYCHIAT, V69, P318, DOI 10.1016/j.biopsych.2010.07.029
- Spijker J, 2001, ACTA PSYCHIAT SCAND, V103, P122, DOI 10.1034/j.1600-0447.2001.103002122.x
- Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b
- Stroke-Recommendations on stroke prevention diagnosis and therapy, 1989, STROKE, V20, P1407
- Talairach J, 1988, COPLANAR STEREOTAXIC
- Tang WK, 2013, CEREBROVASC DIS, V35, P566, DOI 10.1159/000351152
- Tchanturia K, 2012, INT J EAT DISORDER, V45, P962, DOI 10.1002/eat.22032
- Terroni L, 2011, WORLD J BIOL PSYCHIA, V12, P539, DOI 10.3109/15622975.2011.562242
- Terroni LDN, 2009, REV BRAS PSIQUIATR, V31, P202, DOI 10.1590/S1516-44462009000300004
- Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006
- Turkcapar MH, 1999, J AFFECT DISORDERS, V54, P101, DOI 10.1016/S0165-0327(98)00146-3
- Vaisvaser S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00313
- van Dalen JW, 2013, STROKE, V44, P851, DOI 10.1161/STROKEAHA.112.674614
- Van Essen DC, 1998, P NATL ACAD SCI USA, V95, P788, DOI 10.1073/pnas.95.3.788
- Vataja R, 2004, J NEUROPSYCH CLIN N, V16, P156, DOI 10.1176/appi.neuropsych.16.2.156
- Vataja R, 2001, ARCH GEN PSYCHIAT, V58, P925, DOI 10.1001/archpsyc.58.10.925
- Velthorst E, 2012, SCHIZOPHR RES, V138, P290, DOI 10.1016/j.schres.2012.03.022
- Wacker J, 2009, NEUROIMAGE, V46, P327, DOI 10.1016/j.neuroimage.2009.01.058
- Wang SH, 2009, PSYCHIAT RES, V170, P245, DOI 10.1016/j.psychres.2008.07.006
- Wang SH, 2010, PHARMACOL BIOCHEM BE, V95, P129, DOI 10.1016/j.pbb.2009.12.017
- Yu Lifa, 2004, Kaohsiung Journal of Medical Sciences, V20, P372
- Zimmerman M, 2013, J CLIN PSYCHIAT, V74, P470, DOI 10.4088/JCP.12m08053
Coleções
Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - LIM/15
Carregar mais Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - LIM/15